Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down0.08% Nasdaq Down0.11%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS

33.50 Up 0.21(0.63%) May 23, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 30, 2013Dec 30, 2012Sep 29, 2012Jun 29, 2012
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development12,122  18,284  15,458  12,590  
Selling General and Administrative3,218  2,771  2,762  2,680  
Non Recurring250   -   -  250  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (15,590) (21,055) (18,220) (15,520)
Income from Continuing Operations
Total Other Income/Expenses Net(78) -   -   -  
Earnings Before Interest And Taxes(15,668)(21,059)(18,268)(15,692)
Interest Expense -   -   -   -  
Income Before Tax(15,668)(21,059)(18,268)(15,692)
Income Tax Expense -   -   -  (35)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(15,668)(21,059)(18,268)(15,657)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (15,668) (21,059) (18,268) (15,657)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (15,668) (21,059) (18,268) (15,657)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.